The results showed that tumor-derived CD8T was significantly activated with macrophages and 10 μM resveratrol-βcd (Figure 4B), indicating that tumor-derived CD8T cells had a phenotype that could be activated by macrophages. This evidence concerns the gene CYP4V2 and neoplasm.